Rischin D - Search Results

1

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.

Migden MR, Rischin D, Schmults CD, Guminski A, Hauschild A, Lewis KD, Chung CH, Hernandez-Aya L, Lim AM, Chang ALS, Rabinowits G, Thai AA, Dunn LA, Hughes BGM, Khushalani NI, Modi B, Schadendorf D, Gao B, Seebach F, Li S, Li J, Mathias M, Booth J, Mohan K, Stankevich E, Babiker HM, Brana I, Gil-Martin M, Homsi J, Johnson ML, Moreno V, Niu J, Owonikoko TK, Papadopoulos KP, Yancopoulos GD, Lowy I, Fury MG. Migden MR, et al. Among authors: rischin d. N Engl J Med. 2018 Jul 26;379(4):341-351. doi: 10.1056/NEJMoa1805131. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863979 Free article. Clinical Trial.

2

Combined modality treatment for locally advanced squamous-cell carcinoma of the oropharynx in a woman with Bloom's syndrome: a case report and review of the literature.

Ma B, Corry J, Rischin D, Leong T, Peters LJ. Ma B, et al. Among authors: rischin d. Ann Oncol. 2001 Jul;12(7):1015-7. doi: 10.1023/a:1011106202939. Ann Oncol. 2001. PMID: 11521786 Free article. Review.

3

Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.

Porceddu SV, Campbell B, Rischin D, Corry J, Weih L, Guerrieri M, Grossi M, Peters LJ. Porceddu SV, et al. Among authors: rischin d. Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):365-73. doi: 10.1016/j.ijrobp.2004.03.011. Int J Radiat Oncol Biol Phys. 2004. PMID: 15380568

4

Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 N0 squamous cell carcinoma of the oral tongue.

Brennan S, Corry J, Kleid S, Porceddu S, Yuen K, Rischin D, Peters LJ. Brennan S, et al. Among authors: rischin d. Head Neck. 2010 Feb;32(2):191-8. doi: 10.1002/hed.21167. Head Neck. 2010. PMID: 19572285 Clinical Trial.

5

Prolonged remission in a patient with nasopharyngeal carcinoma with a solitary bone metastasis.

Lim A, Corry J, Lau E, Rischin D. Lim A, et al. Among authors: rischin d. J Clin Oncol. 2011 Feb 20;29(6):e135-7. doi: 10.1200/JCO.2010.31.9053. Epub 2010 Dec 6. J Clin Oncol. 2011. PMID: 21135283 No abstract available.

6

Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.

Young RJ, Rischin D, Fisher R, McArthur GA, Fox SB, Peters LJ, Corry J, Lim A, Waldeck K, Solomon B. Young RJ, et al. Among authors: rischin d. Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1230-7. doi: 10.1158/1055-9965.EPI-10-1262. Epub 2011 Apr 5. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21467228

7

Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.

Lim AM, Rischin D, Fisher R, Cao H, Kwok K, Truong D, McArthur GA, Young RJ, Giaccia A, Peters L, Le QT. Lim AM, et al. Among authors: rischin d. Clin Cancer Res. 2012 Jan 1;18(1):301-7. doi: 10.1158/1078-0432.CCR-11-2295. Epub 2011 Nov 17. Clin Cancer Res. 2012. PMID: 22096023 Free PMC article. Clinical Trial.

8

A phase 3 trial of bevacizumab in ovarian cancer.

Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM; ICON7 Investigators. Perren TJ, et al. N Engl J Med. 2011 Dec 29;365(26):2484-96. doi: 10.1056/NEJMoa1103799. N Engl J Med. 2011. PMID: 22204725 Free article. Clinical Trial.

9

Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinoma.

Lim AM, Young RJ, Collins M, Fox SB, McArthur GA, Corry J, Peters L, Rischin D, Solomon B. Lim AM, et al. Among authors: rischin d. Oral Oncol. 2012 Aug;48(8):698-702. doi: 10.1016/j.oraloncology.2012.02.014. Epub 2012 Mar 11. Oral Oncol. 2012. PMID: 22410096

10

The impact of preradiation residual disease volume on time to locoregional failure in cutaneous Merkel cell carcinoma--a TROG substudy.

Finnigan R, Hruby G, Wratten C, Keller J, Tripcony L, Dickie G, Rischin D, Poulsen M. Finnigan R, et al. Among authors: rischin d. Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):91-5. doi: 10.1016/j.ijrobp.2012.11.026. Epub 2013 Jan 3. Int J Radiat Oncol Biol Phys. 2013. PMID: 23290441 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page